NetEase, Inc. $NTES Stake Decreased by Advyzon Investment Management LLC

Advyzon Investment Management LLC reduced its holdings in NetEase, Inc. (NASDAQ:NTES) by 35.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,397 shares of the technology company’s stock after selling 4,622 shares during the quarter. Advyzon Investment Management LLC’s holdings in NetEase were worth $1,276,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. NewSquare Capital LLC boosted its position in NetEase by 137.2% during the 2nd quarter. NewSquare Capital LLC now owns 185 shares of the technology company’s stock worth $25,000 after acquiring an additional 107 shares during the period. Private Trust Co. NA grew its position in NetEase by 266.0% in the 2nd quarter. Private Trust Co. NA now owns 194 shares of the technology company’s stock valued at $26,000 after buying an additional 141 shares in the last quarter. Cornerstone Planning Group LLC bought a new position in NetEase in the 3rd quarter valued at about $33,000. Spire Wealth Management increased its stake in NetEase by 159.6% during the 2nd quarter. Spire Wealth Management now owns 257 shares of the technology company’s stock valued at $35,000 after buying an additional 158 shares during the period. Finally, Steigerwald Gordon & Koch Inc. bought a new stake in shares of NetEase during the 3rd quarter worth about $38,000. Institutional investors own 11.07% of the company’s stock.

Analysts Set New Price Targets

NTES has been the subject of a number of research analyst reports. Sanford C. Bernstein set a $155.00 price target on shares of NetEase in a research note on Friday, November 21st. Benchmark reissued a “buy” rating on shares of NetEase in a report on Thursday, February 12th. Citigroup restated a “buy” rating on shares of NetEase in a research report on Wednesday, February 11th. Barclays dropped their price objective on NetEase from $135.00 to $132.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 12th. Finally, Nomura lowered their target price on NetEase from $160.00 to $155.00 and set a “buy” rating on the stock in a report on Friday, February 13th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $155.67.

NetEase Stock Performance

Shares of NASDAQ:NTES opened at $118.41 on Friday. The company has a market cap of $75.02 billion, a PE ratio of 16.13, a price-to-earnings-growth ratio of 1.50 and a beta of 0.71. NetEase, Inc. has a 52 week low of $88.54 and a 52 week high of $159.55. The firm has a 50 day simple moving average of $132.84 and a 200 day simple moving average of $138.68.

NetEase Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 27th. Stockholders of record on Monday, March 16th will be issued a $1.16 dividend. The ex-dividend date is Monday, March 16th. This is an increase from NetEase’s previous quarterly dividend of $0.57. This represents a $4.64 dividend on an annualized basis and a dividend yield of 3.9%. NetEase’s dividend payout ratio is currently 30.93%.

NetEase Company Profile

NetEase, Inc (NASDAQ: NTES) is a Chinese technology company headquartered in Hangzhou that develops and operates Internet services and products. Founded in 1997 by William Ding (Ding Lei), the company has grown from an early web portal and e-mail provider into a diversified online services group. William Ding has served as the company’s founder and long-time leader, guiding its expansion into games, digital content and consumer services.

The company’s primary business is interactive entertainment: NetEase Games designs, develops and publishes PC and mobile games for domestic and international audiences, offering a mix of self-developed franchises and titles published under licensing and strategic partnerships.